Q&A - Questions & Answers

Yes. We welcome both online meetings and on-site visits to our manufacturing facility in Warsaw. A manufacturing facility audit is a standard part of selecting a long-term contract manufacturing partner. During your visit, we can present our production lines and machinery, R&D and analytical laboratories, quality control procedures and GMP documentation systems. Our manufacturing facility operates in accordance with ISO 22716 (Cosmetic GMP), certified by TÜV SÜD Polska. Our processes are documented and prepared for external verification. To arrange an on-site visit or an online meeting, please contact us via the contact form.

Yes. MG Evolution's manufacturing facility is certified according to ISO 22716 (Cosmetic GMP – Good Manufacturing Practices for Cosmetics) by TÜV SÜD Polska. The certification confirms that every stage of the manufacturing process – from raw material receipt to the release of the finished product – is controlled and documented in accordance with European GMP requirements. For your brand, this means properly documented manufacturing processes supporting the Product Information File (PIF), a robust quality management framework and production standards suitable for demanding European and international markets. In addition to ISO 22716, MG Evolution operates according to ISO 14001 for environmental management and ISO 13485 for medical device quality management.

Every cosmetic product placed on the European Union market requires documentation compliant with Regulation (EC) No 1223/2009. MG Evolution supports the preparation of complete regulatory documentation, including: PIF (Product Information File) – complete product documentation required in the EU, including product description, formulation, manufacturing method, safety assessment and relevant test results; CPNP notification – notification through the EU Cosmetic Products Notification Portal before the product is placed on the market; INCI – list of ingredients according to the International Nomenclature of Cosmetic Ingredients; SDS/MSDS – relevant safety data sheets; Cosmetic Product Safety Report / Safety Assessment – prepared and supervised by our in-house Safety Assessor.

Yes. MG Evolution works with international clients and manufactures cosmetic products for export outside the EU, including GCC countries such as Saudi Arabia, the United Arab Emirates, Kuwait and Qatar, as well as markets in Africa, Asia and the United States. For exports outside the EU, the client provides the regulatory requirements applicable to the target market. Based on these requirements, MG Evolution can adapt product documentation, labelling and, where necessary, the formulation. Products are manufactured in Poland in accordance with ISO 22716 Cosmetic GMP.

The total project lead time depends on its scope and complexity. Typical timelines are: first formulation samples: approx. 3–4 weeks after receiving the brief; sample adjustments: approx. 2 weeks per iteration; testing: up to 12 weeks, depending on the required scope; manufacturing: approx. 10–14 weeks from order confirmation. The total timeline is typically around 20–30 weeks for a formulation developed from scratch or 14–20 weeks when working with an existing formulation.

Starting a project with MG Evolution involves several straightforward steps:

1. Send us your product brief – describe the product type, expected performance, target group, estimated volume and target market.

2. Schedule an initial meeting – during a short video call, we will discuss your concept and define the preliminary project scope.

3. Sign an NDA – before confidential information is exchanged.

4. Quotation and timeline – after analysing the brief, we prepare a project quotation and proposed schedule.

5. R&D begins – our laboratories start developing the first formulation samples. You do not need a ready-made formulation or previous experience in the cosmetics industry. We can manage the process from the initial concept through R&D, testing and documentation to manufacturing and packaging.